Keros Therapeutics Leases 35,662 SF at Revolution Labs in Lexington


BOSTON – Greatland Realty Partners, a Boston-based real estate development firm, along with joint-venture partner Singerman Real Estate, announced the signing of a long-term lease agreement with Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS) at Revolution Labs in Lexington, MA.

The terms of the deal include an 8-year lease agreement for 35,662 square feet within the brand-new, state of the art 180,000 square foot development in the heart of the nation’s leading life sciences, pharmaceutical, and biotech super cluster.

Greatland and Singerman were represented by JLL in the transaction, with Keros represented by CBRE. The lease is the first deal signed at the property, which will be ready for occupancy in Q4 of 2022. Callahan Construction Managers is the general contractor for the project.

“We are thrilled to welcome Keros as our first customer at Revolution Labs in Lexington,” said Teri Ford, Director of Development at Greatland. “Revolution Labs will deliver an unmatched work experience and provide Keros with brand new, state of the art lab space to support its continued scientific research and development activities.”

Designed by architecture firm SGA, Revolution Labs is optimally situated at 1050 Waltham Street in Lexington, MA just south of Route 2 in a walkable, mixed-use neighborhood with convenient access to Interstate 95. Less than 15 minutes from Boston/Cambridge, Revolution Labs offers 180,000 square feet of state of the art, lab ready infrastructure, along with LEED Gold, WELL Building and WiredScore Gold certifications, and numerous onsite amenities such as covered parking, fitness, dining, and ample meeting and outdoor space.